BioAxial, a developer and seller of Conical Diffraction Microscopy (CODIM) technology, has been granted a US patent covering ‘black fluorophore’ technology, which will be included in the second generation of CODIM products.
Patents
Black fluorophore is an important component of ‘dark tracking’ technology, which belongs to a new family of super resolution techs in microscopy that is expected to achieve tracking or imaging at only a few nanometres , or even a single nanometre, with low light levels.
This new patent strengthens the company’s existing patent portfolio, which already comprises ten patent families, and will build on the company’s position within the field of commercial super-resolution imaging modules.
“This patent presents a major boost for the life sciences industry. Dark tracking can become a key modality in fluorescence microscopy, which is already an essential tool in fundamental biology, medical research and drug discovery,” said Gabriel Sirat, CSO at BioAxial. “This is a clear recognition of our scientific achievements and gives us a strong IP standing in the field.”
“Today CODIM has been adopted by pharma and academic users in Europe, Japan and North America; dark tracking will greatly benefit our system’s second generation. It will improve considerably the performance and applicability of our CODIM modules,” commented Georges Tabary, president and CEO at BioAxial. “Our intention is to widen its adoption by collaborating with all scientific and industrial players in the field.”
BioAxial customers and partners will be readily able to use both standard CODIM and dark tracking technologies, using the same hardware, with the ability to switch from one to the other swiftly, as required. The company has integrated dark tracking into its current development roadmap and plans to commercialize new products with this technology.